Nachrichten zur MacroGenics Inc. Aktie

MacroGenics to Participate in Upcoming Investor Conference

ROCKVILLE, MD, May 17, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

6 Analysts Have This to Say About Macrogenics

Macrogenics (NASDAQ:MGNX) has observed the following analyst ratings within the last quarter: Latest Ratings for MGNX DateFirmActionFromTo…

Why MacroGenics Stock Is Tanking Today

Investors found plenty to dislike about the companys Q1 update....…

Macrogenics: Q1 Earnings Insights

Macrogenics (NASDAQ:MGNX) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:00 PM. Heres what investors need to know…

MacroGenics Non-GAAP EPS of -$1.08 misses by $0.23, revenue of $11.1M misses by $12.08M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Provides Update on Corporate Progress and First Quarter 2022 Financial Results

ROCKVILLE, Md., May 03, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing…

MacroGenics Announces Date of First Quarter 2022 Financial Results Conference Call

ROCKVILLE, MD, April 25, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

What 4 Analyst Ratings Have To Say About Macrogenics

Analysts have provided the following ratings for Macrogenics (NASDAQ:MGNX) within the last quarter: Latest Ratings for MGNX …

MacroGenics upgraded to buy at Citi on valuation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics promotes Eric Risser to COO

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why MacroGenics Stock Is Sinking Today

The company provided a disappointing Q4 update....…

MacroGenics: Facing Considerable Headwinds From Unsatisfactory Trials

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics (MGNX) Q4 2021 Earnings Call Transcript

MGNX earnings call for the period ending December 31, 2021....…

MacroGenics, Inc. (MGNX) CEO Scott Canning on Q4 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Recap: Macrogenics Q4 Earnings

Macrogenics (NASDAQ:MGNX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Heres what investors need to know…

Form 8-K MACROGENICS INC For: Feb 24

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Provides Update on Corporate Progress and 2021 Financial Results

ROCKVILLE, Md., Feb. 24, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing…

MacroGenics (MGNX) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Announces Date of Fourth Quarter 2021 Financial Results Conference Call

ROCKVILLE, MD, Feb. 14, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

Macrogenics started at outperform with $31 stock price target at BMO Capital

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics to Participate in Upcoming Investor Conferences

ROCKVILLE, MD, Feb. 03, 2022 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

Synaffix, MacroGenics Ink Pact For Next Generation Antibody-Drug Conjugates

Synaffix BV has read more...…

Synaffix and MacroGenics collaborate for gen-ex ADCs

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Global LAG 3 Inhibitor Market Research Report 2022-2028 Featuring Key Players - MacroGenics, Zai Lab, Bristol-Myers Squibb, Ono Pharmaceuticals, Immutep, Novartis, Merck, F-star Therapeutics

DUBLIN, Jan. 31, 2022 /PRNewswire/ -- The "Global LAG 3 Inhibitor Clinical Trials & Market Opportunity Insight 2028" report has…

Form 8-K MACROGENICS INC For: Jan 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics, Inc. 2021 Q3 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics, Inc. (MGNX) CEO Scott Koenig on Q3 2021 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics to Participate in Upcoming Investor Conferences

ROCKVILLE, MD, Nov. 03, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

MacroGenics (MGNX) Q3 2021 Earnings Call Transcript

MGNX earnings call for the period ending September 30, 2021....…

MacroGenics (MGNX) Reports Q3 Loss, Misses Revenue Estimates

MacroGenics (MGNX) delivered earnings and revenue surprises of -36.51% and -60.41%, respectively, for the quarter ended September 2021. Do the…

MacroGenics Provides Update on Corporate Progress and Third Quarter 2021 Financial Results

ROCKVILLE, Md., Nov. 02, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing…

MacroGenics Announces Date of Third Quarter 2021 Financial Results Conference Call

ROCKVILLE, MD, Oct. 26, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 2.063.960$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2021-09-28...…

Notable Insider Buys Of The Past Week Include Designer Brands, MacroGenics And More

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. The weeks most notable…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 8.376.800$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2021-09-16...…

Insiderhandel: Insider kauft Aktien von MacroGenics im Wert von 3.986.680$

Biotech, Target N V. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2021-09-17...…

MacroGenics posts biggest one-day loss; cancer drug data draw mixed views from SVB Leerink

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MACROGENICS INC: 8-K Report

8-K...…

MacroGenics (MGNX) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

MacroGenics Shares Fall After MGC018 Data Fails To Impress At ESMO Presentation

MacroGenics Inc (NASDAQ: MGNX) read more...…

Why MacroGenics Stock Is Tanking Today

Investors werent thrilled with the companys latest clinical data....…

MacroGenics Announces Preliminary Clinical Results from Phase 1 Cohort Expansion of the Ongoing MGC018 Study Presented at ESMO 2021 Virtual Annual Congress

ROCKVILLE, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing…

MacroGenics Announces Clinical Results from Cohort A Part 1 of Phase 2/3 MAHOGANY Study of Margetuximab in Combination with Retifanlimab in Gastroesophageal Adenocarcinoma at ESMO 2021

ROCKVILLE, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing…

MacroGenics Announces Final Overall Survival Results from SOPHIA Study of MARGENZA™ in Patients with HER2-Positive Metastatic Breast Cancer

ROCKVILLE, MD, Sept. 07, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on developing…